Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Stazzone Peter received 50,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Stazzone Peter (Chief Financial Officer) received 50,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 100,000 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 100,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Award | 50,000 | 100,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Stazzone Peter
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Stazzone Peter · Apr 17, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026
- Form 4 · Holloway Michael Andrew · Jul 2, 2026